OREGON PRIMARY CARE PROVIDERS AS A FRONTLINE DEFENSE IN THE WAR ON MELANOMA TM : IMPROVING ACCESS TO MELANOMA EDUCATION

Alyssa Becker ¹ Jacob Nelson ^2* Alex Verdieck-Devlaeminck ³ Elizabeth G Berry ² Victoria E Orfaly ² Elizabeth R Stoos ² Jessica Tran ² Emile Latour ⁴ Vikram N Sahni ^2,5 Shuai Xu ⁶ Megan Babcock ² Anna Bar ² Mirna Becevic ⁷ Candace Chan ² Duncan Chisholm ² Kyra Diehl ² Karen Edison ⁷ Laura K Ferris ⁸ Emilie A Foltz ⁹ Alan C Geller ¹⁰ Heidi Jacobe ¹¹ Mariah M Johnson ² Patrick Kinghorn ² Justin Leitenberger ² Joanna Ludzik ² Danielle Mcclanahan ² Stephanie Mengden-Koon ² Kelly Nelson ¹² Ryan Petering ³ Smriti Prasad ² Adam Roscher ³ Stephanie Savory ¹¹ Emily H Smith ⁸ Susan M Swetter ¹² Susan Tofte ² Martin A. Weinstock ^13,14 Kevin White ² Oliver Wisco ^13,15 Alexander Witkowski ² Sancy A Leachman ^16,2

• ¹ John A. Burns School of Medicine, University of Hawai’i at Mānoa, Honolulu, United States
• ² Department of Dermatology, Oregon Health & Science University, Portland, United States
• ³ Department of Family Medicine, Oregon Health & Science University, Portland, United States
• ⁴ Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, United States
• ⁵ College of Medicine, Drexel University, Philadelphia, Pennsylvania, United States
• ⁶ Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
• ⁷ Department of Dermatology, School of Medicine, University of Missouri, Columbia, Missouri, United States
• ⁸ Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, United States
• ⁹ Elson S. Floyd College of Medicine, Washington State University Spokane, Spokane, Washington, United States
• ¹⁰ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, United States
• ¹¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, United States
• ¹² Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, United States
• ¹³ Department of Dermatology, Warren Alpert Medical School, Brown University, Province, Rhode Island, United States
• ¹⁴ Center for Dermatoepidemiology, Providence Veteran Affairs Medical Center, Providence, United States
• ¹⁵ Dermatology Health Specialists, Bend, United States
• ¹⁶ Knight Cancer Institute, Oregon Health & Science University, Portland, United States

Melanoma is one of the deadliest forms of skin cancer but is typically cured with surgical excision when detected early. As an access point to medical care, primary care providers (PCP) play an integral role in early skin cancer detection. However, limited time for examinations and dermatologic training may present barriers to effective skin examination in the primary care setting. As a facet of Oregon Health & Science University's War on Melanoma TM (WoM), our multi-pronged outreach initiative aims to provide PCPs across Oregon with free, convenient, and effective melanoma education. The WoM PCP education campaign was disseminated starting in May 2019 through primary care networks throughout the state of Oregon to 12,792 PCPs, and education was delivered across several platforms: online multimedia tools, large group didactics, individualized practicebased sessions, and in-person distribution of materials to clinics. To date, 829 PCPs have participated in the online Melanoma Toolkit for Early Detection curriculum, 1,874 providers have attended CME didactics, and 9 clinics have received facilitated meetings by Oregon Rural Practice-based Research Network. Eighty-three clinics (comprising 770 providers) were visited on-site and provided educational materials, and more than 150 PCPs have received a free smartphone dermatoscope to aid in skin examination and e-consultation. OHSU's WoM has successfully implemented a multifaceted approach to provide accessible melanoma education to PCPs across the state of Oregon. As a result, we hope to encourage appropriate skin examination in the primary care setting and improve PCPs' diagnostic accuracy and confidence in pigmented lesion evaluation.